Will Akero's (AKRO) NASH Data Delight Investors?

Akero Therapeutics Inc. (AKRO), which completed its IPO last June, has since gained more than 30 percent and trades around $24.

from RTT - Biotech https://ift.tt/2vTqVrl
via IFTTT